Literature DB >> 3181371

Reduction of the number of mice used for potency testing of human and animal rabies vaccines.

L Bruckner1, M Palatini, M Ackermann, H K Müller, U Kihm.   

Abstract

Eight different rabies vaccines were tested for their potency in the standard mouse potency test using 3-, 5- and 7-week-old mice. 5-week-old mice seem to be best suited for this purpose, variability from test to test could be reduced considerably. An ELISA was used in parallel for the evaluation of the rabies glycoprotein content of rabies vaccines. Results of the mouse potency test correlated well with those of the ELISA if highly purified human vaccines were tested. Unspecific reactions in the ELISA caused by adjuvanted veterinary vaccines could not be blocked. Further experiments will be needed in order to evaluate the potency of inactivated veterinary rabies vaccines by a in vitro test.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3181371     DOI: 10.1007/bf01941183

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  5 in total

1.  Rabies vaccines: duration-of-immunity study in dogs.

Authors:  R K Sikes; G V Peacock; P Acha; R J Arko; R Dierks
Journal:  J Am Vet Med Assoc       Date:  1971-12-01       Impact factor: 1.936

2.  A single-radial-immunodiffusion technique for the assay of rabies glycoprotein antigen: application for potency tests of vaccines against rabies.

Authors:  M Ferguson; G C Schild
Journal:  J Gen Virol       Date:  1982-03       Impact factor: 3.891

3.  Laboratory techniques in rabies: the antibody binding test for vaccine potency.

Authors:  R J Arko; T J Wiktor; R K Sikes
Journal:  Monogr Ser World Health Organ       Date:  1973

4.  Rabies virus glycoprotein. II. Biological and serological characterization.

Authors:  J H Cox; B Dietzschold; L G Schneider
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

5.  [Correlation between the NIH test and the seroneutralizing antibodies obtained after vaccination in the dog].

Authors:  G Chappuis; G Tixier
Journal:  Comp Immunol Microbiol Infect Dis       Date:  1982       Impact factor: 2.268

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.